256 Newsroom — Uganda's Digital News Infrastructure
Business

FDA approves pancreatic cancer drug that extends patients’ lives - The Washington Post

Published by The Washington Post By Daniel Wu · 27 August 2026 at 02:54
Share
FDA approves pancreatic cancer drug that extends patients’ lives - The Washington Post
Image · The Washington Post

What the report says

In trials, Revolution Medicines’ daraxonrasib nearly doubled average survival times for one of the deadliest cancers.

Read the full report at The Washington Post →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

More stories by this journalist

Other publications from this journalist — open any story without leaving the article page.

No other published stories from this publisher yet.

Related reporting

Spiro Partners With Yadea to Scale Electric Mobility Across AfricaNile Post Mesach Semakula Partners With I&M Bank for ‘50 Years of Greatness’ ConcertNile Post Government Eases Poultry Genetics Import Rules to Address Layer Chick ShortageNile Post 256 Newsroom Govt warns poor business advice hurting Ugandan enterprises - Daily MonitorDaily Monitor SSEBUNYA ANDREW: Egypt’s desert farmers are turning agriculture into a youth tech revolutionWatchdog Uganda Two Decades of Impact: How MSC Supported SAO Zirobwe SACCO is Transforming LuweeroSoftPower News